Regeneron Pharmaceuticals Beats On Libtayo's Back, Unveils Dividend
Regeneron Pharmaceuticals Beats On Libtayo's Back, Unveils Dividend · Investor's Business Daily

In This Article:

Regeneron stock jumped Tuesday after the biotech giant topped Wall Street's December-quarter calls on the back of its cancer drug Libtayo.